About
Peptinovo develops a drug delivery platform using their patented PALM™ carrier technology to improve the efficacy and reduce side effects of chemotherapy drugs for treating solid tumors, with a lead candidate currently in pre-IND testing.
Explore Peptinovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.